We’d like to share some exciting news from Maine. Last week the state’s legislature passed a bill to allow mail-order importation from international pharmacies. The bill, “An Act To Facilitate the Licensing of International Mail Order Prescription Pharmacies by the Maine Board of Pharmacy” (LD 171), negates a September 2012 ruling by Maine Attorney General William Schneider that prohibited non-U.S. pharmacies from selling to Maine customers.read more
Our Mission Statement
RxRights is a coalition concerned about the high cost of U.S. pharmaceuticals. We are dedicated to promoting and protecting American consumer access to sources of safe, affordable prescription drugs.
Our Coalition represents millions of people like you, struggling to fight the tide of increasing drug costs.
Why do Americans pay more?
Access to safe and affordable pharmaceuticals should be a natural right for all Americans. Yet there are incredible discrepancies between brand name and generic pharmaceuticals around the globe. On average, Americans pay twice as much for prescription medicine as people in other industrialized countries. Why? Because big pharmaceutical companies engage in underhanded tactics like price fixing and censorship. Pharmaceutical manufacturers have gone to great lengths to protect the high prices of their products in America.
There are plenty of statistics out there related to prescription drug prices and spending. One measure that has us particularly concerned is medication nonadherence. That is, when people simply stop taking their medication. When people don't take their meds as prescribed, we know that it compounds their health problems. It results in additional trips to the emergency room, which adds to overall health care costs.
We've heard many stories of Americans having to choose between buying medicine and other essentials, such as groceries. We know that cost is a huge factor in nonadherence. And this problem is growing. A new study shows that 50 million Americans (age 19-64) didn't fill a prescription in 2012 due to cost. This number is up 2 million from the previous year. And the nonadherence number would clearly be much higher if older adults had been included in the study.read more
follow us on:
Protect access to affordable medicine! Join me in tweeting obo @rxrights! http://rxrights.org #rxrights
In The News
- Mon, 17 Jun 2013
- Fri, 14 Jun 2013
- Tue, 4 Jun 2013
- Fri, 31 May 2013